POST BREXIT

With the transition period between the UK and EU now complete, the MHRA has published their guidance for pharmaceutical and device companies. Alongside the MHRA Portal which is up and running.

Due to the volume of information released, JensonR+ colleagues are going to release a series of blog posts highlighting any key information for your companies, including:

  • Access to Northern Ireland
  • Marketing Authorisation Holder guidance

At JensonR+ we can help support you with any Brexit related changes, with services ranging from Consultancy Advice to implementing and managing Quality Management Systems. With Regulatory, Quality and Pharmacovigilance teams on hand to offer their knowledge and experience.

Please do not hesitate to get in touch with us.

CONTACT US